104 related articles for article (PubMed ID: 32407486)
21. ZD0870 treatment of murine candidiasis caused by fluconazole resistant isolates of Candida albicans.
Najvar LK; Correa A; James P; Luther MF; Graybill JR
J Antimicrob Chemother; 1996 Oct; 38(4):671-7. PubMed ID: 8937961
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics-pharmacodynamics of a sordarin derivative (GM 237354) in a murine model of lethal candidiasis.
Aviles P; Falcoz C; San Roman R; Gargallo-Viola D
Antimicrob Agents Chemother; 2000 Sep; 44(9):2333-40. PubMed ID: 10952576
[TBL] [Abstract][Full Text] [Related]
23. In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model.
Andes D; Marchillo K; Stamstad T; Conklin R
Antimicrob Agents Chemother; 2003 Oct; 47(10):3165-9. PubMed ID: 14506026
[TBL] [Abstract][Full Text] [Related]
24. New azole antifungals with a fused triazinone scaffold.
Montoir D; Guillon R; Gazzola S; Ourliac-Garnier I; Soklou KE; Tonnerre A; Picot C; Planchat A; Pagniez F; Le Pape P; Logé C
Eur J Med Chem; 2020 Mar; 189():112082. PubMed ID: 32000050
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, characterization and antifungal activity of a novel formulated nanocomposite containing Indolicidin and Graphene oxide against disseminated candidiasis.
Farzanegan A; Roudbary M; Falahati M; Khoobi M; Gholibegloo E; Farahyar S; Karimi P; Khanmohammadi M
J Mycol Med; 2018 Dec; 28(4):628-636. PubMed ID: 30126717
[TBL] [Abstract][Full Text] [Related]
26. Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV
Shokri H; Sharifzadeh A
J Mycol Med; 2017 Jun; 27(2):159-165. PubMed ID: 28159362
[TBL] [Abstract][Full Text] [Related]
27.
Zhao M; Lepak AJ; VanScoy B; Bader JC; Marchillo K; Vanhecker J; Ambrose PG; Andes DR
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378706
[TBL] [Abstract][Full Text] [Related]
28. Effect of plant oils on Candida albicans.
Agarwal V; Lal P; Pruthi V
J Microbiol Immunol Infect; 2010 Oct; 43(5):447-51. PubMed ID: 21075713
[TBL] [Abstract][Full Text] [Related]
29. Characterization and quantitation of the pharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis infection model.
Andes D; van Ogtrop M
Antimicrob Agents Chemother; 1999 Sep; 43(9):2116-20. PubMed ID: 10471550
[TBL] [Abstract][Full Text] [Related]
30. Antifungal activity and potential mechanism of Asiatic acid alone and in combination with fluconazole against Candida albicans.
Wang Y; Lu C; Zhao X; Wang D; Liu Y; Sun S
Biomed Pharmacother; 2021 Jul; 139():111568. PubMed ID: 33845374
[TBL] [Abstract][Full Text] [Related]
31. Repurposing of Ribavirin as an Adjunct Therapy against Invasive
Yousfi H; Cassagne C; Ranque S; Rolain JM; Bittar F
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307986
[TBL] [Abstract][Full Text] [Related]
32. Correlation between in vitro and in vivo activity of antifungal agents against Candida species.
Anaissie EJ; Karyotakis NC; Hachem R; Dignani MC; Rex JH; Paetznick V
J Infect Dis; 1994 Aug; 170(2):384-9. PubMed ID: 8035024
[TBL] [Abstract][Full Text] [Related]
33. Fluphenazine antagonizes with fluconazole but synergizes with amphotericin B in the treatment of candidiasis.
Lu Y; Zhou Z; Mo L; Guo Q; Peng X; Hu T; Zhou X; Ren B; Xu X
Appl Microbiol Biotechnol; 2019 Aug; 103(16):6701-6709. PubMed ID: 31201451
[TBL] [Abstract][Full Text] [Related]
34. Lack of correlation of 24- vs. 48-h itraconazole minimum inhibitory concentrations with microbiological and survival outcomes in a guinea pig model of disseminated candidiasis.
Odabasi Z; Paetznick VL; Rodriguez JR; Chen E; Rex JH; Leitz GJ; Ostrosky-Zeichner L
Mycoses; 2010 Sep; 53(5):438-42. PubMed ID: 19500259
[TBL] [Abstract][Full Text] [Related]
35. Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits.
Petraitiene R; Petraitis V; Groll AH; Candelario M; Sein T; Bell A; Lyman CA; McMillian CL; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 1999 Sep; 43(9):2148-55. PubMed ID: 10471556
[TBL] [Abstract][Full Text] [Related]
36. Colorimetric MTT assessment of antifungal activity of D0870 against fluconazole-resistant Candida albicans.
Yang HC; Mikami Y; Yazawa K; Taguchi H; Nishimura K; Miyaji M; Branchini ML; Aoki FH; Yamamoto K
Mycoses; 1998 Dec; 41(11-12):477-80. PubMed ID: 9919890
[TBL] [Abstract][Full Text] [Related]
37. Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata.
Dovigo LN; Pavarina AC; Mima EG; Giampaolo ET; Vergani CE; Bagnato VS
Mycoses; 2011 Mar; 54(2):123-30. PubMed ID: 19889173
[TBL] [Abstract][Full Text] [Related]
38. Liposomal thymoquinone effectively combats fluconazole-resistant Candida albicans in a murine model.
Khan MA; Aljarbou AN; Khan A; Younus H
Int J Biol Macromol; 2015 May; 76():203-8. PubMed ID: 25709021
[TBL] [Abstract][Full Text] [Related]
39. Ambroxol Hydrochloride Combined with Fluconazole Reverses the Resistance of
Li X; Zhao Y; Huang X; Yu C; Yang Y; Sun S
Front Cell Infect Microbiol; 2017; 7():124. PubMed ID: 28439502
[TBL] [Abstract][Full Text] [Related]
40. Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans.
Ng SM; Yap YY; Cheong JW; Ng FM; Lau QY; Barkham T; Teo JW; Hill J; Chia CS
J Pept Sci; 2017 Mar; 23(3):215-221. PubMed ID: 28105725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]